JP2009046421A - Skin care preparation for external use - Google Patents
Skin care preparation for external use Download PDFInfo
- Publication number
- JP2009046421A JP2009046421A JP2007213655A JP2007213655A JP2009046421A JP 2009046421 A JP2009046421 A JP 2009046421A JP 2007213655 A JP2007213655 A JP 2007213655A JP 2007213655 A JP2007213655 A JP 2007213655A JP 2009046421 A JP2009046421 A JP 2009046421A
- Authority
- JP
- Japan
- Prior art keywords
- yeast extract
- skin
- amino acid
- external preparation
- liposome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 67
- 150000001413 amino acids Chemical class 0.000 claims abstract description 92
- 229940024606 amino acid Drugs 0.000 claims abstract description 87
- 239000002502 liposome Substances 0.000 claims abstract description 75
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 72
- 239000012138 yeast extract Substances 0.000 claims abstract description 72
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 14
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 14
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 14
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims abstract description 12
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 8
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 8
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 8
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 8
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 8
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 8
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004472 Lysine Substances 0.000 claims abstract description 8
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004473 Threonine Substances 0.000 claims abstract description 8
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960000310 isoleucine Drugs 0.000 claims abstract description 8
- 229930182817 methionine Natural products 0.000 claims abstract description 8
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004474 valine Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 abstract description 12
- 230000014759 maintenance of location Effects 0.000 abstract description 5
- -1 aliphatic amino acid Chemical class 0.000 description 37
- 230000003020 moisturizing effect Effects 0.000 description 19
- 150000003904 phospholipids Chemical class 0.000 description 19
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000006071 cream Substances 0.000 description 13
- 239000000499 gel Substances 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000008213 purified water Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000004359 castor oil Substances 0.000 description 8
- 235000019438 castor oil Nutrition 0.000 description 8
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 229960005323 phenoxyethanol Drugs 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 229940056692 resinol Drugs 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 229920002907 Guar gum Polymers 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 229940042880 natural phospholipid Drugs 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 235000011118 potassium hydroxide Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 2
- 206010057248 Cell death Diseases 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000008344 egg yolk phospholipid Substances 0.000 description 2
- 229940068998 egg yolk phospholipid Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000028043 self proteolysis Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- HEORQRHVQJVWEH-UHFFFAOYSA-N (3-hydroxy-2,2-dimethylpropyl) dihydrogen phosphate Chemical compound OCC(C)(C)COP(O)(O)=O HEORQRHVQJVWEH-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ZBTWVMAWWXIQHU-UHFFFAOYSA-N OC(=O)CCCCCCCCC.OC(=O)CCCCCCCCC.N1=C(C)C(O)=C(CO)C(CO)=C1 Chemical compound OC(=O)CCCCCCCCC.OC(=O)CCCCCCCCC.N1=C(C)C(O)=C(CO)C(CO)=C1 ZBTWVMAWWXIQHU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- GZJYBYBQDJAIJV-UHFFFAOYSA-N [2,2-bis(hydroxymethyl)-3-octanoyloxypropyl] octanoate Chemical compound CCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCC GZJYBYBQDJAIJV-UHFFFAOYSA-N 0.000 description 1
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N alpha-n-hexadecene Natural products CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
本発明は、リポソームを含有した皮膚外用剤に関する。 The present invention relates to an external preparation for skin containing liposomes.
肌をみずみずしくし、潤いを与えるために、従来より保湿作用を有する化合物を配合した皮膚外用剤が提供されてきている。酵母抽出物は安全性も高く、保湿作用を有する重要な化合物の一つである。しかしながら、酵母抽出物の保湿作用は必ずしも高くなく、酵母抽出物を配合した皮膚外用剤による、肌に対する保湿作用は充分とは言えない。酵母抽出物を配合した皮膚外用剤の先行技術としては、パック、クリーム、乳液等の例がある(特許文献1、2、3、4及び5参照)。 In order to freshen and moisturize the skin, an external preparation for skin containing a compound having a moisturizing action has been conventionally provided. Yeast extract has high safety and is one of important compounds having a moisturizing action. However, the moisturizing action of the yeast extract is not necessarily high, and it cannot be said that the moisturizing action on the skin by the external preparation for skin containing the yeast extract is sufficient. Examples of the prior art of a skin external preparation containing a yeast extract include packs, creams, and emulsions (see Patent Documents 1, 2, 3, 4 and 5).
一方、薬効成分の薬効を向上させるために薬効成分をリポソーム化する技術が知られているが、酵母抽出物を包含したリポソームについては知られていない。なお、本発明に係る化合物であるアミノ酸を包含したリポソームについては皮膚外用剤に関する技術が公開されている(例えば、特許文献6及び7参照)。 On the other hand, in order to improve the medicinal efficacy of medicinal ingredients, a technique for making medicinal ingredients into liposomes is known, but liposomes containing yeast extract are not known. In addition, about the liposome containing the amino acid which is the compound which concerns on this invention, the technique regarding a skin external preparation is published (for example, refer patent document 6 and 7).
本発明は上記事情に鑑みてなされたもので、その目的は、酵母抽出物配合の皮膚外用剤の保湿作用を高め、肌に優れた保湿感を与える皮膚外用剤を提供することにある。 This invention is made | formed in view of the said situation, The objective is to provide the skin external preparation which improves the moisturizing effect of the skin external preparation mix | blended with a yeast extract, and gives the skin the outstanding moisturizing feeling.
本発明者らは上記課題を解決するために鋭意研究を行った結果、酵母抽出物を特定のアミノ酸と共にリポソーム化し、皮膚外用剤中に含有させることにより上記課題が解決されることを見出し、本発明を完成するに至った。 As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that the above-mentioned problems can be solved by converting the yeast extract into a liposome together with a specific amino acid and containing it in a skin external preparation. The invention has been completed.
すなわち、本発明は、次の成分(A)及び(B):
(A)酵母抽出物、
(B)トリプトファン及びヒスチジンからなる群から選ばれる一種又は二種のアミノ酸
を包含するリポソームを含有する皮膚外用剤である。
That is, the present invention includes the following components (A) and (B):
(A) yeast extract,
(B) An external preparation for skin containing liposomes containing one or two amino acids selected from the group consisting of tryptophan and histidine.
本発明においては、前記成分(B)に、さらに、バリン、ロイシン、イソロイシン、スレオニン、リジン、メチオニン及びフェニルアラニンからなる群から選ばれる一種又は二種以上のアミノ酸を含有することにより、さらに保湿作用が増強するので好ましい実施態様である。 In the present invention, the component (B) further contains one or two or more amino acids selected from the group consisting of valine, leucine, isoleucine, threonine, lysine, methionine, and phenylalanine, thereby providing a moisturizing action. This is a preferred embodiment because it enhances.
本発明によれば、酵母抽出物と特定のアミノ酸をリポソームに包含させて、皮膚外用剤に配合することにより、肌に優れた保湿感を与える皮膚外用剤が得られる。本発明の皮膚外用剤は、毎日使用することによりさらに優れた保湿効果が発揮される。 ADVANTAGE OF THE INVENTION According to this invention, the skin external preparation which gives the skin a moisturizing feeling excellent by including a yeast extract and a specific amino acid in a liposome, and mix | blending with a skin external preparation is obtained. The skin external preparation of the present invention exhibits a further excellent moisturizing effect when used daily.
以下、本発明を実施するための最良の形態について詳述する。 Hereinafter, the best mode for carrying out the present invention will be described in detail.
本発明において用いられる酵母抽出物における酵母としては、特に限定されないが、例えば、パン酵母、ビール酵母、ワイン酵母、清酒酵母等を挙げることができる。本発明において用いられる酵母抽出物としては、酵母の極性溶媒による抽出物、酵母を自己消化、酸加水分解又は酵素分解等により溶菌させた後ろ過したもの、あるいは前記溶菌液を乾燥し、それより極性溶媒で抽出したものを用いることができるが、これらに限定されることはなく、酵母抽出物の形態としては、溶媒を含んだ抽出液等であっても、溶媒を除去したペースト又は粉末のものであっても何れの形態でも使用可能である。なお、抽出に使用する極性溶媒としては、例えば、水、エタノール、1,3−ブチレングリコール、プロピレングリコール、グリセリン、又はこれらの任意の混合溶媒が用いられる。 Although it does not specifically limit as yeast in the yeast extract used in this invention, For example, baker's yeast, beer yeast, wine yeast, sake yeast, etc. can be mentioned. Examples of the yeast extract used in the present invention include an extract with a polar solvent of yeast, a yeast lysed by autolysis, acid hydrolysis, enzymatic degradation, or the like, or the lysate is dried, Those extracted with a polar solvent can be used, but the present invention is not limited to these, and the form of the yeast extract may be a paste or powder from which the solvent has been removed even if it is an extract containing the solvent. It can be used in any form. In addition, as a polar solvent used for extraction, water, ethanol, 1, 3- butylene glycol, propylene glycol, glycerol, or these arbitrary mixed solvents are used, for example.
酵母抽出物は、抽出された粗抽出物をそのまま、または、さらにろ過、濃縮等をおこなって精製抽出物として用いることができる。本発明においては、酵母抽出物として市販されているものを用いることができる。市販品としては、例えば、チトカタライザー(山川貿易株式会社製)、Biodynes(株式会社GSIクレオス製)等が挙げられる。前記チトカタライザーは、パン酵母の中の有効成分を自己消化法により処理し、抽出・濃縮・無臭化した水溶性抽出物である。本発明における酵母抽出物の配合量は、乾燥純分として皮膚外用剤全量中7.5×10−3〜1.0質量%が好ましい。 The yeast extract can be used as a purified extract as it is or after further filtration, concentration and the like. In this invention, what is marketed as a yeast extract can be used. Examples of commercially available products include chito catalyzer (manufactured by Yamakawa Trading Co., Ltd.), Biodynes (manufactured by GSI Creos Co., Ltd.), and the like. The cytocatalyzer is a water-soluble extract obtained by treating, and extracting, concentrating, and non-bromating an active ingredient in baker's yeast by an autolysis method. The blending amount of the yeast extract in the present invention is preferably 7.5 × 10 −3 to 1.0% by mass in the total amount of the external preparation for skin as a dry pure component.
本発明においては、必須成分として、トリプトファン及びヒスチジンからなる群から選ばれる一種又は二種のアミノ酸が用いられる。トリプトファン及びヒスチジンは異節環状アミノ酸(以下、(異)とも表す。)であり、いずれも公知の物質である。本発明における前記トリプトファン及びヒスチジンからなる群から選ばれる一種又は二種のアミノ酸の配合量は皮膚外用剤全量中7.75×10−7〜10.0質量%が好ましい。本発明においては、前記トリプトファン及びヒスチジンからなる群から選ばれる一種又は二種のアミノ酸に加えて、バリン、ロイシン、イソロイシン、スレオニン、リジン及びメチオニンからなる脂肪族アミノ酸(以下、(脂)とも表す。)、フェニルアラニンからなる芳香族アミノ酸(以下、(芳)とも表す。)を配合することができる。前記バリン、ロイシン、イソロイシン、スレオニン、リジン、メチオニン及びフェニルアラニンは、これらの群から選ばれる一種又は二種以上を用いることができるが、全てを配合することが好ましい。これらのアミノ酸を配合することにより、保湿作用をさらに増強させることができる。前記本発明におけるトリプトファン、ヒスチジン(異節環状アミノ酸)、バリン、ロイシン、イソロイシン、スレオニン、リジン、メチオニン(脂肪族アミノ酸)、フェニルアラニン(芳香族アミノ酸)の9種のアミノ酸は、いわゆる必須アミノ酸として知られている。なお、前記バリン、ロイシン、イソロイシン、スレオニン、リジン、メチオニン及びフェニルアラニンからなる群から選ばれる一種又は二種以上のアミノ酸を配合する場合においては、前記トリプトファン及びヒスチジンからなる群から選ばれる一種又は二種のアミノ酸と併せた量として皮膚外用剤全量中7.75×10−7〜10.0質量%であることが好ましい。 In the present invention, one or two amino acids selected from the group consisting of tryptophan and histidine are used as essential components. Tryptophan and histidine are allocyclic amino acids (hereinafter also referred to as (different)), both of which are known substances. In the present invention, the amount of one or two amino acids selected from the group consisting of tryptophan and histidine is preferably 7.75 × 10 −7 to 10.0 mass% in the total amount of the external preparation for skin. In the present invention, in addition to one or two amino acids selected from the group consisting of tryptophan and histidine, an aliphatic amino acid (hereinafter referred to as (fatty)) consisting of valine, leucine, isoleucine, threonine, lysine and methionine. ), An aromatic amino acid composed of phenylalanine (hereinafter also referred to as (good)). The valine, leucine, isoleucine, threonine, lysine, methionine and phenylalanine can be used singly or in combination of two or more selected from these groups, but all are preferably blended. By blending these amino acids, the moisturizing action can be further enhanced. The nine amino acids in the present invention, known as tryptophan, histidine (heterocyclic amino acid), valine, leucine, isoleucine, threonine, lysine, methionine (aliphatic amino acid), and phenylalanine (aromatic amino acid) are known as so-called essential amino acids. ing. In the case of blending one or two or more amino acids selected from the group consisting of valine, leucine, isoleucine, threonine, lysine, methionine and phenylalanine, one or two types selected from the group consisting of tryptophan and histidine It is preferable that it is 7.75 * 10 < -7 > -10.0 mass% in the skin external preparation whole quantity as a quantity combined with this amino acid.
本発明においては、アミノ酸として、必須成分である前記異節環状アミノ酸に、さらに、前記脂肪族アミノ酸及び/又は前記芳香族アミノ酸を配合する場合、異節環状アミノ酸量1質量部に対して、脂肪族アミノ酸量を6〜10質量部、芳香族アミノ酸を0.5〜2.0質量部の範囲で配合することが好ましい。 In the present invention, as the amino acid, when the aliphatic amino acid and / or the aromatic amino acid is further added to the heterocylic cyclic amino acid that is an essential component, It is preferable to mix 6 to 10 parts by mass of the aromatic amino acid and 0.5 to 2.0 parts by mass of the aromatic amino acid.
本発明の皮膚外用剤において、酵母抽出物と前記アミノ酸はリン脂質を構成成分とするリポソームに包含させて皮膚外用剤中に含有される。リポソーム化により酵母抽出物と前記アミノ酸配合による保湿効果が顕著に発揮される。 In the external preparation for skin of the present invention, the yeast extract and the amino acid are contained in the external preparation for skin by inclusion in a liposome containing phospholipid as a constituent component. The moisturizing effect by the yeast extract and the amino acid combination is remarkably exhibited by the formation of liposome.
リポソーム化に用いられるリン脂質としては、化粧料、医薬部外品、医薬品等に使用されるものであれば特に限定されない。なお、本発明においてリン脂質とは、天然リン脂質、水素添加リン脂質等のリン脂質誘導体、合成リン脂質等を含めた概念のものである。リン脂質としては、例えば、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトール、スフィンゴミエリン等の天然リン脂質、天然リン脂質中の不飽和炭素鎖を水素により飽和とした水素添加リン脂質、ジオレイルホスファチジルコリン等の合成リン脂質等が挙げられる。本発明においては、大豆リン脂質、卵黄リン脂質等のリン脂質、水素添加大豆リン脂質、水素添加卵黄リン脂質等の水素添加リン脂質、合成リン脂質を用いることが好ましく、水素添加リン脂質がさらに好ましく、特に水素添加大豆リン脂質が好ましい。リン脂質は、その1種を単独で使用してもよく、又は2種以上を適宜組み合わせて使用してもよい。 The phospholipid used for liposome formation is not particularly limited as long as it is used for cosmetics, quasi drugs, pharmaceuticals and the like. In the present invention, phospholipid is a concept including natural phospholipids, phospholipid derivatives such as hydrogenated phospholipids, synthetic phospholipids, and the like. Examples of phospholipids include natural phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, and sphingomyelin, hydrogenated phospholipids in which unsaturated carbon chains in natural phospholipids are saturated with hydrogen, and dioleylphosphatidylcholine. Synthetic phospholipids and the like. In the present invention, it is preferable to use phospholipids such as soybean phospholipid and egg yolk phospholipid, hydrogenated soybean phospholipid, hydrogenated phospholipid such as hydrogenated egg yolk phospholipid, and synthetic phospholipid. Hydrogenated soybean phospholipid is particularly preferable. One phospholipid may be used alone, or two or more phospholipids may be used in appropriate combination.
リポソームの安定化の目的でコレステロール、グルコース、高級アルコール、非イオン性界面活性剤、イオン性界面活性剤等の安定化剤を添加することができる。前記リポソームの安定化剤は、例えば、前記リポソーム調製の際にリン脂質等と共に混合され、リポソームの一構成成分とすることができる。 Stabilizers such as cholesterol, glucose, higher alcohols, nonionic surfactants, ionic surfactants and the like can be added for the purpose of stabilizing liposomes. The liposome stabilizer can be mixed with a phospholipid or the like during the preparation of the liposome, for example, to be a constituent component of the liposome.
前記非イオン界面活性剤の例としては、ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、ポリオキシエチレン(以下、POEという。)ソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、POEソルビタンモノステアレート等)、POEソルビット脂肪酸エステル類(POEソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POEグリセリンモノイソステアレート等)、ポリエチレングリコール(以下、PEGという。)脂肪酸エステル類(PEGモノオレエート、PEGジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・ポリオキシプロピレン(以下、POPという。)アルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等を挙げることができる。非イオン界面活性剤は1種または2種以上が任意に選択されて配合される。 Examples of the nonionic surfactant include sorbitan fatty acid esters (such as sorbitan monostearate and sorbitan sesquioleate), glycerin fatty acids (such as glyceryl monostearate), and propylene glycol fatty acid esters (propylene glycol monostearate). ), Hydrogenated castor oil derivative, glycerin alkyl ether, polyoxyethylene (hereinafter referred to as POE) sorbitan fatty acid esters (POE sorbitan monooleate, POE sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE sorbite mono) Laurate, etc.), POE glycerin fatty acid esters (POE glycerin monoisostearate, etc.), polyethylene glycol (hereinafter referred to as PEG) fatty acid esters (PEG monoo Ate, PEG distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl ether, etc.), pluronic types, POE polyoxypropylene (hereinafter referred to as POP) alkyl. Examples include ethers (POE / POP2-decyltetradecyl ether), tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), sucrose fatty acid esters, alkyl glucosides, and the like. it can. One or more nonionic surfactants are arbitrarily selected and blended.
酵母抽出物と前記アミノ酸を包含するリポソームの調製にあたっては、特に限定されることなく、超音波法、ホモミキサー法、薄膜法、注入法、界面活性剤除去法等既知の方法で調製することができる。例えば、リン脂質に、もし必要であれば多価アルコール、コレステロール等の安定化剤を加熱混合し、溶解する。その後、酵母抽出物及びアミノ酸を、例えば酵母抽出物液及びアミノ酸液の形で添加し、撹拌混合し、そこに水を加え、さらに撹拌混合する。その後、高圧ミキサー(例えばマイクロフルイダイザーのような高圧乳化機やAPVホモジナイザー等)で処理しリポソームを形成させる。次いで、加温した場合は、室温まで冷却してリポソーム液を得る。なお、高圧ミキサー処理する混合物が分散液の場合は、処理する前の工程で高速撹拌(例えば、ホモミキサーで3000rpm以上の撹拌速度)等により分散を高めることが好ましい。 The preparation of the liposome containing the yeast extract and the amino acid is not particularly limited and may be prepared by a known method such as an ultrasonic method, a homomixer method, a thin film method, an injection method, or a surfactant removal method. it can. For example, if necessary, a stabilizer such as polyhydric alcohol or cholesterol is heated and mixed with phospholipid and dissolved. Thereafter, the yeast extract and the amino acid are added, for example, in the form of a yeast extract solution and an amino acid solution, mixed with stirring, added with water, and further mixed with stirring. Thereafter, it is treated with a high-pressure mixer (for example, a high-pressure emulsifier such as a microfluidizer or an APV homogenizer) to form liposomes. Next, when warmed, the solution is cooled to room temperature to obtain a liposome solution. In addition, when the mixture to be processed by the high-pressure mixer is a dispersion, it is preferable to increase the dispersion by high-speed stirring (for example, stirring speed of 3000 rpm or more with a homomixer) in the step before the processing.
また、前記例示した製法において、リン脂質等の成分で、酵母抽出物及び/又はアミノ酸を除いたリポソームを調製し、次いで該リポソームと前記除いた成分(酵母抽出物及び/又はアミノ酸)、必要であればその他の包含成分をさらに混合して撹拌、好ましくは高速撹拌する等前記と同様にして調製することもできる。さらに、充分な量の酵母抽出物及び/又はアミノ酸が包含されていないリポソーム、あるいは酵母抽出物及び/又はアミノ酸が全く包含されていないリポソームを調製し、次いで必要量になるように、酵母抽出物及び/又はアミノ酸等を混合して前記同様にして調製することも可能である。これらの方法による酵母抽出物及びアミノ酸を包含したリポソームを調製するに当たっては、例えば、市販されている酵母抽出物及びアミノ酸が包含されていないリポソームを利用することが可能であり、これの利用により品質の安定した酵母抽出物及びアミノ酸高濃度包含のリポソームが効率的に得られる。 Further, in the production method exemplified above, a liposome from which a yeast extract and / or an amino acid is removed with a component such as phospholipid is prepared, and then the liposome and the removed component (yeast extract and / or amino acid) are necessary. If present, other inclusion components can be further mixed and stirred, preferably at high speed, and the like, and the like. Furthermore, a yeast extract containing a sufficient amount of yeast extract and / or amino acid, or a liposome containing no yeast extract and / or amino acid, and then preparing the required amount It is also possible to prepare the mixture in the same manner as described above by mixing amino acids and the like. In preparing liposomes containing yeast extract and amino acids by these methods, for example, commercially available yeast extract and liposomes not containing amino acids can be used. A stable yeast extract and a liposome containing a high concentration of amino acids can be efficiently obtained.
市販されている前記酵母抽出物及びアミノ酸が包含されていないリポソームの例としては、例えばNIKKOL アクアソーム BH、同LA(以上、日光ケミカルズ社製)等が挙げられる。本発明においてはこれらの市販品をそのまま用いてもよいが、リポソームの濃度を高める等本発明の皮膚外用剤を調製するに当たって使いやすい仕様に変換して用いることも効率的な方法である。 Examples of the commercially available yeast extract and liposomes not containing amino acids include NIKKOL Aquasome BH and LA (manufactured by Nikko Chemicals). In the present invention, these commercially available products may be used as they are, but it is also an efficient method to convert them into specifications that are easy to use in preparing the external preparation for skin of the present invention, such as increasing the concentration of liposomes.
リポソームは、リン脂質の二分子膜の一重層あるいは多重層からなる球状の小胞体で、酵母抽出物及び/又はアミノ酸がリン脂質の膜中または小胞体内に取り込まれた状態(包含)となる。リポソームの粒子径は平均粒径30〜200nmであることが好ましい。中でも40〜100nmがより好ましい。平均粒径が200nmを超えると肌への浸透化が劣るようになり好ましくない。なお、リポソームの粒子径は、濃厚系粒径アナライザーFPAR−1000(大塚電子株式会社製、光散乱光度計)を用いて室温にて測定した。 Liposomes are spherical vesicles consisting of a single layer or multiple layers of a phospholipid bilayer, and the yeast extract and / or amino acids are incorporated (included) in the phospholipid membrane or endoplasmic reticulum. . The particle diameter of the liposome is preferably an average particle diameter of 30 to 200 nm. Among these, 40 to 100 nm is more preferable. When the average particle size exceeds 200 nm, the penetration into the skin is inferior, which is not preferable. In addition, the particle diameter of the liposome was measured at room temperature using a concentrated particle size analyzer FPAR-1000 (manufactured by Otsuka Electronics Co., Ltd., light scattering photometer).
リポソームは、一般的には、水分散液として存在し、水に任意に希釈される。皮膚外用剤中においても皮膚外用剤中の水に任意に希釈されるが、本発明におけるリポソームとは、皮膚外用剤中に存在する任意に希釈されたリポソーム水分散液を含む概念である。 Liposomes are generally present as aqueous dispersions and are optionally diluted in water. In the skin external preparation, it is optionally diluted with water in the skin external preparation. The liposome in the present invention is a concept including an optionally diluted liposome aqueous dispersion present in the skin external preparation.
本発明においては、酵母抽出物と前記アミノ酸をリポソームに包含させて皮膚外用剤中に含有されるが、前記リポソームとしては、酵母抽出物と前記アミノ酸の混合されたものが包含されたリポソームばかりでなく、皮膚外用剤中のリポソーム内に所定の酵母抽出物と前記アミノ酸が存在すればよい。例えば、酵母抽出物及び前記アミノ酸それぞれ別々に包含されたリポソームの、それぞれのリポソームを皮膚外用剤中に含有させても構わない。さらに、アミノ酸として混合物を用いる場合についても、混合されたアミノ酸を包含したリポソームばかりでなく、それぞれ一種のアミノ酸又は任意の種類混合されたアミノ酸を包含したリポソームを、それぞれを皮膚外用剤中に含有させても構わない。なお、酵母抽出物についても、二種以上を用いる場合はアミノ酸の場合と同じである。本発明においては、これらのリポソームの態様を全て含めたものとして、請求項1及び2の表現をとっている。すなわち、例えば、請求項1には、次の成分(A):
(A)酵母抽出物
を包含するリポソーム及び次の成分(B):
(B)トリプトファン及びヒスチジンからなる群から選ばれる一種又は二種のアミノ酸
を包含するリポソームを含有する皮膚外用剤が含まれるものである。本発明においては、酵母抽出物と前記アミノ酸の混合されたものが包含されたリポソームが保湿効果の点で好ましい。
In the present invention, the yeast extract and the amino acid are included in the liposome and contained in the external preparation for skin. However, the liposome is only a liposome containing a mixture of the yeast extract and the amino acid. The predetermined yeast extract and the amino acid may be present in the liposome in the external preparation for skin. For example, each of the yeast extract and the liposome separately contained in the amino acid may be contained in the external preparation for skin. Further, in the case of using a mixture as an amino acid, not only liposomes containing mixed amino acids but also liposomes containing one kind of amino acid or any kind of mixed amino acid are included in the external preparation for skin. It doesn't matter. In addition, also about a yeast extract, when using 2 or more types, it is the same as the case of an amino acid. In the present invention, the expressions of claims 1 and 2 are taken as including all the embodiments of these liposomes. That is, for example, claim 1 includes the following component (A):
(A) Liposomes containing yeast extract and the following component (B):
(B) A skin external preparation containing liposomes containing one or two amino acids selected from the group consisting of tryptophan and histidine is included. In the present invention, a liposome containing a mixture of a yeast extract and the amino acid is preferable in terms of a moisturizing effect.
酵母抽出物及びアミノ酸を包含したリポソームを皮膚外用剤中に含有させるに当たっては、酵母抽出物及びアミノ酸が包含されていないか、又は所定量の酵母抽出物及びアミノ酸が包含されていないリポソームと、酵母抽出物及びアミノ酸を皮膚外用剤処方の一成分として配合して、皮膚外用剤調製時に酵母抽出物及びアミノ酸を所定量包含したリポソームを形成させても構わない。 When the liposome containing the yeast extract and amino acid is contained in the external preparation for skin, the yeast extract and amino acid are not included, or the liposome does not include a predetermined amount of the yeast extract and amino acid, and the yeast. An extract and an amino acid may be blended as one component of a skin external preparation formulation, and a liposome containing a predetermined amount of the yeast extract and amino acid may be formed when preparing the skin external preparation.
本発明の皮膚外用剤には、前記成分の他に、通常化粧品、医薬部外品、医薬品等の皮膚外用剤に用いられる他の成分を本発明の効果を損なわない範囲で適宜配合することができる。前記任意配合成分としては、成分中に含まれる物質が複数の成分に該当する場合がある記載であり、また前記と一部重なる記載も含まれるが、例えば、油分、界面活性剤、保湿剤、多価アルコール、増粘剤、水溶性高分子、皮膜形成剤、非水溶性高分子、油ゲル化剤、高分子エマルジョン、粉末、顔料、染料、レーキ、低級アルコール、糖類、紫外線吸収剤、前記以外のアミノ酸類、ビタミン類、美白剤,皮膚賦活剤,血行促進剤,抗脂漏剤,抗炎症剤(消炎剤)等の薬剤、植物抽出物、有機酸、有機アミン、金属イオン封鎖剤、pH調整剤、酸化防止剤、抗菌剤(防腐殺菌剤)、収斂剤、清涼剤、香料、水等を挙げることができる。 In the external preparation for skin of the present invention, in addition to the above-mentioned components, other components that are usually used in external preparations for skin such as cosmetics, quasi-drugs, and pharmaceuticals can be appropriately blended within a range that does not impair the effects of the present invention. it can. As the optional compounding component, a substance contained in the component may be a plurality of components, and includes a description partially overlapping with the above, for example, oil, surfactant, humectant, Polyhydric alcohol, thickener, water-soluble polymer, film forming agent, water-insoluble polymer, oil gelling agent, polymer emulsion, powder, pigment, dye, lake, lower alcohol, saccharide, UV absorber, Non-amino acids, vitamins, whitening agents, skin activators, blood circulation promoters, antiseborrheic agents, anti-inflammatory agents (anti-inflammatory agents), plant extracts, organic acids, organic amines, sequestering agents, A pH adjuster, antioxidant, antibacterial agent (preservative antiseptic), astringent, refreshing agent, fragrance, water and the like can be mentioned.
前記任意配合成分のうち、油分の具体的な例としては、例えば、硬化油、モクロウ、カカオ脂、硬化ヒマシ油、オリーブ油、ヒマシ油、マカデミアナッツ油、月見草油等の油脂;ミツロウ、ラノリン、ゲイロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ホホバロウ、ホホバ油、液状ラノリン等のロウ類;固形パラフィン、セレシン、マイクロクリスタリンワックス、ポリエチレンワックス、流動パラフィン、スクワラン、ポリブテン、揮発性炭化水素等の炭化水素油;パルミチン酸セチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、2−エチルヘキサン酸セチル、ミリスチン酸オクチルドデシル、ステアリン酸オクチル、パルミチン酸オクチル、アジピン酸ジイソプロピル、セバチン酸ジ2−エチルヘキシル、ジカプリン酸ネオペンチルグリコール、トリミリスチン酸グリセリル、トリ−2−エチルヘキサン酸グリセリル、トリオクタン酸グリセリル、トリイソステアリン酸グリセリル、ジイソステアリン酸ジグリセリル、トリイソステアリン酸ジグリセリル、テトラ2−エチルヘキサン酸ペンタエリトリット、ジオクタン酸ペンタエリトリット、トリ2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、リンゴ酸ジイソステアリル等のエステル油;ステアリン酸、パルミチン酸、ミリスチン酸、12−ヒドロキシステアリン酸、ベへン酸、イソステアリン酸、オレイン酸等の高級脂肪酸;セチルアルコール、ステアリルアルコール、セトステアリルアルコール、ベヘニルアルコール、イソステアリルアルコール、オレイルアルコール、オクチルドデカノール等の高級アルコール、ジメチルポリシロキサン,メチルフェニルポリシロキサン,ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン,デカメチルシクロペンタシロキサン,ドデカメチルシクロヘキサシロキサン等環状シリコーン、アミノ変性ポリシロキサン,アルキル変性ポリシロキサン,フッ素変性ポリシロキサン等の変性ポリシロキサン等を挙げることができる。油分は、1種または2種以上が任意に選択されて配合することができる。 Of the optional ingredients, specific examples of the oil include oils such as hydrogenated oil, owl, cacao butter, hydrogenated castor oil, olive oil, castor oil, macadamia nut oil, evening primrose oil; beeswax, lanolin, gay wax, Candelilla wax, carnauba wax, ibota wax, jojoba wax, jojoba oil, liquid lanolin and other waxes; solid paraffin, ceresin, microcrystalline wax, polyethylene wax, liquid paraffin, squalane, polybutene, volatile hydrocarbons and other hydrocarbon oils; Cetyl acid, isopropyl myristate, isopropyl palmitate, cetyl 2-ethylhexanoate, octyldodecyl myristate, octyl stearate, octyl palmitate, diisopropyl adipate, di-2-ethylhexyl sebacate, dica Neopentyl glycol phosphate, glyceryl trimyristate, glyceryl tri-2-ethylhexanoate, glyceryl trioctanoate, glyceryl triisostearate, diglyceryl diisostearate, diglyceryl triisostearate, pentaerythritol tetra-2-ethylhexanoate, Ester oils such as pentaerythritol dioctanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, diisostearyl malate; stearic acid, palmitic acid, myristic acid, 12-hydroxystearic acid, behe Higher fatty acids such as acid, isostearic acid and oleic acid; cetyl alcohol, stearyl alcohol, cetostearyl alcohol, behenyl alcohol, isostearyl alcohol Higher alcohols such as oleyl alcohol and octyldodecanol, chain polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane and diphenylpolysiloxane, cyclic such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane Examples thereof include modified polysiloxanes such as silicone, amino-modified polysiloxane, alkyl-modified polysiloxane, and fluorine-modified polysiloxane. One or more oil components can be arbitrarily selected and blended.
前記任意配合成分のうち、多価アルコールの具体的な例としては、例えば、グリセリン、1,3−ブチレングリコール(1,3−BG)、1,2−ペンタンジオール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール(DPG)、ジグリセリン等が挙げられる。多価アルコールは1種または2種以上が任意に選択されて配合される。 Among the optional blending components, specific examples of the polyhydric alcohol include, for example, glycerin, 1,3-butylene glycol (1,3-BG), 1,2-pentanediol, erythritol, sorbitol, xylitol, multi Tall, propylene glycol, dipropylene glycol (DPG), diglycerin and the like. One or more polyhydric alcohols are arbitrarily selected and blended.
前記任意配合成分のうち、保湿剤の具体的な例としては、例えば、乳酸塩(ナトリウム等)、ピロリドンカルボン酸ナトリウム(PCAソーダ)、尿素等を挙げることができる。保湿剤は1種または2種以上が任意に選択されて配合される。 Specific examples of the humectant among the optional ingredients include lactate (sodium, etc.), sodium pyrrolidonecarboxylate (PCA soda), urea, and the like. One or more moisturizers are arbitrarily selected and blended.
前記任意配合成分のうち、水溶性高分子の具体的な例としては、例えば、グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、プルラン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸、ローカストビーンガム、サクシノグルカン、カロニン酸、キチン、キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、PEG等が挙げられる。水溶性高分子は1種または2種以上が任意に選択されて配合することができる。 Among the optional components, specific examples of the water-soluble polymer include, for example, guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, pullulan, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose. Carboxymethyl cellulose, methyl hydroxypropyl cellulose, chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran, kerato sulfate, Locust bean gum, succinoglucan, caronic acid, chitin, chitosan, carboxymethyl chitin, agar, polyvinyl alcohol Lumpur, polyvinyl pyrrolidone, carboxyvinyl polymer, sodium polyacrylate, PEG, and the like. One or more water-soluble polymers can be arbitrarily selected and blended.
本発明の皮膚外用剤は前記成分を配合して常法にしたがって調製することができる。また、前記のように、皮膚外用剤の調製に際して、皮膚外用剤の調製と同時にリポソームを形成させてもよい。 The external preparation for skin of the present invention can be prepared according to a conventional method by blending the above components. Further, as described above, when preparing the skin external preparation, liposomes may be formed simultaneously with the preparation of the skin external preparation.
本発明皮膚外用剤の形態としては、特に限定されないが、例えば、乳液、クリーム、化粧水、パック等が挙げられる。また、剤型としては、特に限定されないが、ジェル、分散液、軟膏、外用液、クリーム等が挙げられ、特に、ジェル系とすることが保湿効果の点から好ましい。 Although it does not specifically limit as a form of this invention skin external preparation, For example, an emulsion, cream, a lotion, a pack, etc. are mentioned. Further, the dosage form is not particularly limited, and examples thereof include gels, dispersions, ointments, liquids for external use, creams, and the like. In particular, the gel type is preferable from the viewpoint of the moisturizing effect.
以下実施例を挙げて本発明を具体的に説明する。配合量は、特に記載のないものは質量%である。実施例の説明に先立ち本発明で用いた効果試験方法について説明する。 Hereinafter, the present invention will be specifically described with reference to examples. The compounding amount is mass% unless otherwise specified. Prior to the description of the examples, the effect test method used in the present invention will be described.
保湿効果
化粧品使用感官能評価経験のある女性パネラー10名によって効果テストを行った。パネラーは、洗顔後に試験品適量を顔に塗布し、塗布後2時間後の保湿感を官能で評価した。
Moisturizing effect An effect test was conducted by 10 female panelists with experience in sensory evaluation of cosmetic use. The panelist applied an appropriate amount of the test product to the face after washing the face, and sensoryly evaluated the moisturizing feeling 2 hours after the application.
(評価基準)
◎:保湿を強く感じる。
○:保湿を感じる。
△:保湿をわずかに感じる。
×:保湿を感じない。
(Evaluation criteria)
A: Strongly moisturized.
○: Moisturizing is felt.
Δ: Slight moisture retention.
X: Moisture retention is not felt.
[アミノ酸液の調製]
表1に掲げた成分を混合してアミノ酸液A〜Dを調製した。
[Preparation of amino acid solution]
The components listed in Table 1 were mixed to prepare amino acid solutions AD.
[酵母抽出物液の調製]
表2に掲げた成分からなる酵母抽出物液A(酵母抽出物乾燥純分として1.5質量%)を調製した。調製には、チトカタライザーBG30(山川貿易株式会社製)を使用した。
[Preparation of yeast extract solution]
A yeast extract liquid A (1.5% by mass as a dry pure yeast extract) comprising the components listed in Table 2 was prepared. For the preparation, chitocatalyzer BG30 (manufactured by Yamakawa Trading Co., Ltd.) was used.
[リポソームの調製]
表3に掲げた成分を用いて以下の方法でリポソームA〜Gを製造した。表3には使用した各成分の割合を質量%(配合量合計100質量%)で示している。なお、アミノ酸液A〜Dは、表1に示したもの、酵母抽出物液Aは表2に示したものである。水素添加大豆リン脂質、グリセリン及びDPGの一部を50℃で混合後、DPGの残部とコレステロールの混合物を添加し、50℃で加熱溶解した。その後、酵母抽出物液A及び該当するアミノ酸液を添加し、撹拌混合した。その後、精製水を加え100質量%とし撹拌混合した。最後に、高圧乳化機(「マイクロフルイダイザー」米国マイクロフルイディックス社製)で処理をしリポソームを得た。得られたリポソームの平均粒子径は45nmであった。なお、表3には、酵母抽出物液Aとアミノ酸液AまたはBを配合した非リポソーム組成物である非リポソームA及びBの成分を掲げた。この非リポソームは各成分を混合して調製した。
[Preparation of liposomes]
Liposomes A to G were produced by the following method using the components listed in Table 3. In Table 3, the ratio of each component used is shown in mass% (total blending amount 100 mass%). The amino acid solutions A to D are those shown in Table 1, and the yeast extract solution A is that shown in Table 2. A part of hydrogenated soybean phospholipid, glycerin and DPG was mixed at 50 ° C., and then the remainder of DPG and cholesterol were added and dissolved by heating at 50 ° C. Thereafter, the yeast extract liquid A and the corresponding amino acid liquid were added and mixed with stirring. Then, purified water was added to make 100% by mass and mixed with stirring. Finally, it was processed with a high-pressure emulsifier (“Microfluidizer” manufactured by Microfluidics, USA) to obtain liposomes. The average particle diameter of the obtained liposome was 45 nm. Table 3 lists the components of non-liposomes A and B, which are non-liposome compositions in which yeast extract liquid A and amino acid liquid A or B are blended. This non-liposome was prepared by mixing each component.
(注)NIKKOLレシノールS−10(日光ケミカルズ社製) (Note) NIKKOL Resinol S-10 (Nikko Chemicals)
[皮膚外用剤の調製]
[実施例1〜4、比較例1〜5]
皮膚外用剤(ジェルクリーム)を表4に示す所定量の成分を加え、ジェル製剤とした。なお、リポソームA〜G及び非リポソームA、Bは表3に示したものである。
[Preparation of external preparation for skin]
[Examples 1 to 4, Comparative Examples 1 to 5]
A predetermined amount of ingredients shown in Table 4 were added to a skin external preparation (gel cream) to obtain a gel preparation. Liposomes A to G and non-liposomes A and B are those shown in Table 3.
上記実施例1〜4、比較例1〜5の皮膚外用剤(ジェルクリーム)につき効果試験を行い、その評価結果を表5に示した。 An effect test was conducted on the external preparations for skin (gel cream) of Examples 1 to 4 and Comparative Examples 1 to 5, and the evaluation results are shown in Table 5.
表5から分かるように、酵母抽出物と、異節環状アミノ酸であるトリプトファン及び/又はヒスチジンを包含させたリポソームを配合した皮膚外用剤は、酵母抽出物のみを包含させたリポソームを配合した皮膚外用剤(比較例1)、トリプトファン又はヒスチジンのみを包含させたリポソームを配合した皮膚外用剤(比較例2、3)及び酵母抽出物とトリプトファン又はヒスチジンの非リポソーム物を配合した皮膚外用剤(比較例4、5)に比較して、相乗的に肌に優れた保湿感を与えることが分かる。さらに、アミノ酸としてトリプトファン及び/又はヒスチジンからなる異節環状アミノ酸に、バリン、ロイシン、イソロイシン、スレオニン、リジン及びメチオニンからなる脂肪族アミノ酸並びにフェニルアラニンからなる芳香族アミノ酸をさらに配合した皮膚外用剤(実施例4)は、肌に対する保湿感がさらに増強していることが分かる。 As can be seen from Table 5, the skin external preparation containing the yeast extract and the liposome containing the cyclic amino acids tryptophan and / or histidine is the skin external preparation containing the liposome containing only the yeast extract. Preparation (Comparative Example 1), external preparation for skin containing liposomes containing only tryptophan or histidine (Comparative Examples 2 and 3) and external preparation for skin containing non-liposomal product of yeast extract and tryptophan or histidine (Comparative Example) 4 and 5), it can be seen that the skin is synergistically excellent in moisturizing feeling. Further, an external preparation for skin which further contains an aliphatic amino acid composed of valine, leucine, isoleucine, threonine, lysine and methionine, and an aromatic amino acid composed of phenylalanine in a heterocyclic amino acid composed of tryptophan and / or histidine as amino acids (Examples) 4) shows that the moisturizing feeling on the skin is further enhanced.
[実施例5〜8]
以下、さらに本発明の表6の組成からなる皮膚外用剤の実施例(実施例5〜8(ジェルクリーム))を示す。なお、製造は実施例1〜4の方法に準じて行った。表6配合のリポソームH〜Kは、表3のものと同様にして調製した表7に示したものを用いた。なお、表7中のアミノ酸液A〜Dは表1に示したものであり、酵母抽出物液Aは表2に示したものである。
[Examples 5 to 8]
Hereinafter, the Example (Examples 5-8 (gel cream)) of the external preparation for skin which consists of a composition of Table 6 of this invention is shown. In addition, manufacture was performed according to the method of Examples 1-4. Liposomes H to K in Table 6 were prepared as shown in Table 7 prepared in the same manner as in Table 3. In addition, the amino acid solutions A to D in Table 7 are those shown in Table 1, and the yeast extract solution A is shown in Table 2.
(注)NIKKOLレシノールS−10(日光ケミカルズ社製) (Note) NIKKOL Resinol S-10 (Nikko Chemicals)
[実施例9〜17]
以下、さらに本発明の表8の組成からなる皮膚外用剤の実施例(実施例9〜17(ジェルクリーム))を示す。なお、製造は実施例1〜4の方法に準じて行った。表8配合のリポソームA、B、L〜Sは、表3に示したもの及び同様にして調製した表9に示したものを用いた。なお、表9中のアミノ酸液E〜Lは表10に示したものであり、酵母抽出物液Aは表2に示したものである。
[Examples 9 to 17]
Hereinafter, the Example (Examples 9-17 (gel cream)) of the external preparation for skin which consists of a composition of Table 8 of this invention is shown. In addition, manufacture was performed according to the method of Examples 1-4. The liposomes A, B, and L to S included in Table 8 were those shown in Table 3 and those shown in Table 9 prepared in the same manner. The amino acid solutions E to L in Table 9 are those shown in Table 10, and the yeast extract solution A is that shown in Table 2.
(注)NIKKOLレシノールS−10(日光ケミカルズ社製) (Note) NIKKOL Resinol S-10 (Nikko Chemicals)
[実施例18〜20]
以下、さらに本発明の皮膚外用剤を示す。なお、用いたアミノ酸及び酵母抽出物液は以下のようにして調製した。
[Examples 18 to 20]
Hereinafter, the external preparation for skin of the present invention will be shown. In addition, the used amino acid and yeast extract liquid were prepared as follows.
[アミノ酸の調製]
表11に掲げた成分を混合してアミノ酸M、Nを調製した。
[Preparation of amino acids]
The components listed in Table 11 were mixed to prepare amino acids M and N.
[酵母抽出物液の調製]
表12に掲げた成分を混合して酵母抽出物乾燥純分として0.4質量%(B)、2.0質量%(C)、4.0質量%(D)の酵母抽出物液B〜Dを調製した。なお、これらの酵母抽出物液はチトカタライザーBG30(山川貿易株式会社製)を用いて調製した。
[Preparation of yeast extract solution]
Ingredients listed in Table 12 were mixed to give a yeast extract dry pure content of 0.4% by mass (B), 2.0% by mass (C), 4.0% by mass (D) of yeast extract B to D was prepared. In addition, these yeast extract liquids were prepared using cytocatalyzer BG30 (made by Yamakawa Trading Co., Ltd.).
実施例18 化粧水
成分 配合量(質量%)
(1)1,3−BG 5.0
(2)DPG 2.0
(3)フェノキシエタノール 0.2
(4)精製水 残量
(5)水素添加大豆リン脂質 1.0
(6)1,3−BG 8.0
(7)コレステロール 0.5
(8)アミノ酸N 0.1
(9)酵母抽出物液B 25.0
(10)精製水 25.0
合計100.0
Example 18 Skin lotion component Amount (% by mass)
(1) 1,3-BG 5.0
(2) DPG 2.0
(3) Phenoxyethanol 0.2
(4) Purified water remaining amount (5) Hydrogenated soybean phospholipid 1.0
(6) 1,3-BG 8.0
(7) Cholesterol 0.5
(8) Amino acid N 0.1
(9) Yeast extract liquid B 25.0
(10) Purified water 25.0
Total 100.0
(製法)
成分(5)〜(10)の混合溶液を50℃で高圧乳化機で処理し、30℃まで冷却して、アミノ酸及び酵母抽出物を包含したリポソームを調製した。成分(1)〜(4)を撹拌溶解し、前記リポソームを加え、撹拌混合して化粧水を得た。
(Manufacturing method)
The mixed solution of component (5)-(10) was processed with the high-pressure emulsifier at 50 degreeC, and it cooled to 30 degreeC, and prepared the liposome which included the amino acid and the yeast extract. Components (1) to (4) were dissolved by stirring, the liposomes were added, and the mixture was stirred and mixed to obtain a skin lotion.
実施例19 化粧水
(1)1,3−BG 5.0
(2)DPG 2.0
(3)フェノキシエタノール 0.2
(4)精製水 残量
(5)水素添加大豆リン脂質 1.0
(6)1,3−BG 8.0
(7)コレステロール 0.5
(8)アミノ酸M 10.0
(9)酵母抽出物液C 25.0
(10)精製水 24.0
合計100.0
Example 19 Lotion (1) 1,3-BG 5.0
(2) DPG 2.0
(3) Phenoxyethanol 0.2
(4) Purified water remaining amount (5) Hydrogenated soybean phospholipid 1.0
(6) 1,3-BG 8.0
(7) Cholesterol 0.5
(8) Amino acid M 10.0
(9) Yeast extract liquid C 25.0
(10) Purified water 24.0
Total 100.0
(製法)
成分(5)〜(10)の混合溶液を50℃で高圧乳化機で処理し、30℃まで冷却して、アミノ酸及び酵母抽出物を包含したリポソームを調製した。成分(1)〜(4)を撹拌溶解し、前記リポソームを加え、撹拌混合して化粧水を得た。
(Manufacturing method)
The mixed solution of component (5)-(10) was processed with the high-pressure emulsifier at 50 degreeC, and it cooled to 30 degreeC, and prepared the liposome which included the amino acid and the yeast extract. Components (1) to (4) were dissolved by stirring, the liposomes were added, and the mixture was stirred and mixed to obtain a skin lotion.
実施例20 クリーム
成分 配合量(質量%)
(1)流動パラフィン 5.0
(2)ステアリン酸2−エチルヘキシル 15.0
(3)ワセリン 3.0
(4)セチルアルコール 1.0
(5)ポリオキシエチレン(20)ソルビタンモノステアレート 1.0
(6)ポリオキシエチレン(20)オレイルエーテル 2.5
(7)DPG 5.0
(8)フェノキシエタノール 0.2
(9)精製水 残量
(10)水素添加大豆リン脂質 1.0
(11)1,3−BG 8.0
(12)コレステロール 0.5
(13)アミノ酸N 10.0
(14)酵母抽出物液D 25.0
(15)精製水 15.0
合計100.0
Example 20 Cream component Blending amount (% by mass)
(1) Liquid paraffin 5.0
(2) 2-ethylhexyl stearate 15.0
(3) Vaseline 3.0
(4) Cetyl alcohol 1.0
(5) Polyoxyethylene (20) sorbitan monostearate 1.0
(6) Polyoxyethylene (20) oleyl ether 2.5
(7) DPG 5.0
(8) Phenoxyethanol 0.2
(9) Purified water remaining amount (10) Hydrogenated soybean phospholipid 1.0
(11) 1,3-BG 8.0
(12) Cholesterol 0.5
(13) Amino acid N 10.0
(14) Yeast extract liquid D 25.0
(15) Purified water 15.0
Total 100.0
(製法)
成分(10)〜(15)の混合溶液を50℃で高圧乳化機で処理し、30℃まで冷却して、アミノ酸及び酵母抽出物を包含したリポソームを調製した。成分(1)〜(9)を80℃で加熱混合溶解し、乳化し、30℃まで冷却し、前記リポソームを添加し、撹拌混合してクリームを得た。
(Manufacturing method)
The mixed solution of components (10) to (15) was treated with a high-pressure emulsifier at 50 ° C. and cooled to 30 ° C. to prepare liposomes containing amino acids and yeast extract. Components (1) to (9) were heated and mixed and dissolved at 80 ° C, emulsified, cooled to 30 ° C, the liposomes were added, and the mixture was stirred and mixed to obtain a cream.
[実施例21〜22]
以下、さらに本発明の皮膚外用剤を示す。
[Examples 21 to 22]
Hereinafter, the external preparation for skin of the present invention will be shown.
実施例21 ジェルクリーム
成分 配合量(質量%)
リポソーム(注1) 23.6
アミノ酸M 1.0
酵母抽出物液C 25.0
グリセリン 7.0
1,3−BG 5.0
DPG 3.0
フェノキシエタノール 0.5
カルボキシビニルポリマー 0.8
メチルポリシロキサン 3.0
ジカプリン酸ピリドキシン 0.1
テトラ2−ヘキシルデカン酸アスコルビル 0.2
アラントイン 0.1
水酸化カリウム 0.3
精製水 残余
合計100.0
Example 21 Gel cream component Amount (% by mass)
Liposomes (Note 1) 23.6
Amino acid M 1.0
Yeast extract liquid C 25.0
Glycerin 7.0
1,3-BG 5.0
DPG 3.0
Phenoxyethanol 0.5
Carboxyvinyl polymer 0.8
Methylpolysiloxane 3.0
Pyridoxine dicaprate 0.1
Ascorbyl tetra-2-hexyldecanoate 0.2
Allantoin 0.1
Potassium hydroxide 0.3
Purified water residue
Total 100.0
(注1)下表13からなる成分を混合し、50〜60℃で高速撹拌処理し、30℃まで冷却して調製されたリポソーム。 (Note 1) Liposomes prepared by mixing the components shown in Table 13 below, stirring at 50-60 ° C at high speed, and cooling to 30 ° C.
(注2)NIKKOLレシノールS−10(日光ケミカルズ社製) (Note 2) NIKKOL Resinol S-10 (Nikko Chemicals)
[製法]
リポソーム(注1)にアミノ酸M及び酵母抽出物液Cを混合して50〜60℃で高速撹拌して、リポソーム(注1)に前記アミノ酸及び前記酵母抽出物を内包させた。一方、精製水にカルボキシビニルポリマーを加えて分散させ、水酸化カリウムを加えて中和してゲルを形成させた。次いで、このゲルに残りの成分を加え、さらに前記アミノ酸及び酵母抽出物を内包させたリポソームを添加して撹拌してジェルクリームを調製した。
[Production method]
The liposome (Note 1) was mixed with the amino acid M and the yeast extract liquid C and stirred at 50 to 60 ° C. at high speed to encapsulate the amino acid and the yeast extract in the liposome (Note 1). On the other hand, carboxyvinyl polymer was added and dispersed in purified water, and potassium hydroxide was added and neutralized to form a gel. Next, the remaining components were added to the gel, and liposomes encapsulating the amino acid and yeast extract were added and stirred to prepare a gel cream.
実施例22 ジェルクリーム
成分 配合量(質量%)
リポソーム(注1) 27.1
アミノ酸N 0.1
酵母抽出物B 25.0
POE(60)硬化ヒマシ油 0.1
グリセリン 3.0
1,3−BG 7.0
フェノキシエタノール 0.5
カルボキシビニルポリマー 0.7
テトラ2−ヘキシルデカン酸アスコルビル 0.2
苛性カリ 0.3
アラントイン 0.1
精製水 残余
合計100.0
Example 22 Gel cream component content (mass%)
Liposomes (Note 1) 27.1
Amino acid N 0.1
Yeast extract B 25.0
POE (60) hydrogenated castor oil 0.1
Glycerin 3.0
1,3-BG 7.0
Phenoxyethanol 0.5
Carboxyvinyl polymer 0.7
Ascorbyl tetra-2-hexyldecanoate 0.2
Caustic potash 0.3
Allantoin 0.1
Purified water residue
Total 100.0
(注1)NIKKOL アクアソーム BH コンク(日光ケミカルズ社製) (Note 1) NIKKOL Aquasome BH Conch (Nikko Chemicals)
[製法]
実施例21と同様にしてジェルクリームを調製した。
[Production method]
A gel cream was prepared in the same manner as in Example 21.
酵母抽出物と特定のアミノ酸を包含させたリポソームを配合した皮膚外用剤は、肌に相乗的な保湿効果を与え、例えば、医薬部外品を含む化粧品、医薬品等の種々の分野に応用される。 A topical skin preparation containing a yeast extract and a liposome containing a specific amino acid gives a synergistic moisturizing effect to the skin, and is applied to various fields such as cosmetics and pharmaceuticals including quasi-drugs. .
Claims (2)
(A)酵母抽出物、
(B)トリプトファン及びヒスチジンからなる群から選ばれる一種又は二種のアミノ酸
を包含するリポソームを含有する皮膚外用剤。 The following components (A) and (B):
(A) yeast extract,
(B) A skin external preparation containing liposomes containing one or two amino acids selected from the group consisting of tryptophan and histidine.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007213655A JP2009046421A (en) | 2007-08-20 | 2007-08-20 | Skin care preparation for external use |
PCT/JP2007/067383 WO2009025062A1 (en) | 2007-08-20 | 2007-09-06 | External preparation for skin |
TW097127333A TW200916118A (en) | 2007-08-20 | 2008-07-18 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007213655A JP2009046421A (en) | 2007-08-20 | 2007-08-20 | Skin care preparation for external use |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009046421A true JP2009046421A (en) | 2009-03-05 |
Family
ID=40377972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007213655A Pending JP2009046421A (en) | 2007-08-20 | 2007-08-20 | Skin care preparation for external use |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2009046421A (en) |
TW (1) | TW200916118A (en) |
WO (1) | WO2009025062A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024048047A1 (en) * | 2022-09-01 | 2024-03-07 | 長谷川香料株式会社 | Pore improver and skin improver |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010235491A (en) * | 2009-03-31 | 2010-10-21 | Nof Corp | Liposome for cosmetic |
JP5495656B2 (en) * | 2009-08-04 | 2014-05-21 | 株式会社マンダム | Emulsified cosmetic for skin |
JP6724228B2 (en) * | 2018-12-11 | 2020-07-15 | サンスター株式会社 | Liposomes encapsulating fats and oils |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627385A1 (en) * | 1988-02-23 | 1989-08-25 | Serobiologiques Lab Sa | Dermatological and cosmetic compsns. - contain lipid phase and nitrogenous cpd. esp. amino acid, oligo or polypeptide |
JPH07285827A (en) * | 1994-04-15 | 1995-10-31 | Noevir Co Ltd | External preparation for skin |
JPH11158055A (en) * | 1997-11-26 | 1999-06-15 | Noevir Co Ltd | Skin lotion |
JP2002037709A (en) * | 2000-07-24 | 2002-02-06 | Noevir Co Ltd | Skin care preparation |
JP2004168763A (en) * | 2002-10-30 | 2004-06-17 | Dsr Corp | Skin cosmetic |
JP2005179313A (en) * | 2003-12-24 | 2005-07-07 | Shu Uemura:Kk | Method for producing base agent for skin cosmetic, and skin cosmetic |
-
2007
- 2007-08-20 JP JP2007213655A patent/JP2009046421A/en active Pending
- 2007-09-06 WO PCT/JP2007/067383 patent/WO2009025062A1/en active Application Filing
-
2008
- 2008-07-18 TW TW097127333A patent/TW200916118A/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627385A1 (en) * | 1988-02-23 | 1989-08-25 | Serobiologiques Lab Sa | Dermatological and cosmetic compsns. - contain lipid phase and nitrogenous cpd. esp. amino acid, oligo or polypeptide |
JPH07285827A (en) * | 1994-04-15 | 1995-10-31 | Noevir Co Ltd | External preparation for skin |
JPH11158055A (en) * | 1997-11-26 | 1999-06-15 | Noevir Co Ltd | Skin lotion |
JP2002037709A (en) * | 2000-07-24 | 2002-02-06 | Noevir Co Ltd | Skin care preparation |
JP2004168763A (en) * | 2002-10-30 | 2004-06-17 | Dsr Corp | Skin cosmetic |
JP2005179313A (en) * | 2003-12-24 | 2005-07-07 | Shu Uemura:Kk | Method for producing base agent for skin cosmetic, and skin cosmetic |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024048047A1 (en) * | 2022-09-01 | 2024-03-07 | 長谷川香料株式会社 | Pore improver and skin improver |
Also Published As
Publication number | Publication date |
---|---|
TW200916118A (en) | 2009-04-16 |
WO2009025062A1 (en) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3125858B1 (en) | Compositions and methods for enhancing the topical application of an acidic benefit agent | |
EP3125857B1 (en) | Compositions and methods for enhancing the topical application of a basic benefit agent | |
JP5508682B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
JP3238264B2 (en) | Cosmetic composition for salicylic acid dosing and its preparation | |
JP3609834B2 (en) | Skin preparation | |
KR100874877B1 (en) | Oil-in-water-in-oil reversed-phase multi-emulsion phase using polyol-in-oil high density nano-concentrated emulsion, and preparation method thereof | |
TWI430813B (en) | Vesicle composition, and external skin preparations | |
JP2012017318A (en) | Liquid crystal and skin external preparation containing the same | |
JP2010047493A (en) | Microcapsule and skin external preparation containing the same | |
JP2009062288A (en) | Percutaneous absorption controller containing sophorolipid and method for producing the same | |
JP2005179313A (en) | Method for producing base agent for skin cosmetic, and skin cosmetic | |
JP4049216B2 (en) | Formulation with liquid crystal structure | |
JP6180816B2 (en) | Topical skin preparation | |
JP2005336127A (en) | External preparation for skin | |
KR100715311B1 (en) | A cosmeticss to promote the transepidermal absorption and stabilize ursolic acid for anti-wrinkle and its manufacturing method thereof | |
JP2013245205A (en) | Skin care composition and cosmetic | |
JP2009046421A (en) | Skin care preparation for external use | |
JP2606761B2 (en) | Moisturizer | |
KR20220091739A (en) | Translucent nanoemulsion containing natural ceramide and cosmetic composition including the same | |
JP2005281133A (en) | Skin care preparation for external use | |
JP5633951B2 (en) | Cosmetics and method for producing the same | |
JP5220998B2 (en) | W / O / W type skin or scalp external preparation containing liposome | |
JP3568983B2 (en) | Hair restorer | |
JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
JP3758646B2 (en) | Method for producing O / W type skin cream |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100618 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130122 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130730 |